amide/inflammation

FIELD OF THE INVENTION This invention relates to the treatment of ophthalmic disorders. In particular, this invention relates to the topical use of certain amide derivatives of flurbiprofen or ketorolac to treat or prevent ophthalmic inflammatory and angiogenesis-related disorders of the posterior

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to the treatment of inflammatory bowel disease (IBD). More specifically, this invention is directed to methods for treating or preventing IBD using amide compounds. This invention is also directed to pharmaceutical

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to the treatment of inflammatory bowel disease (IBD). More specifically, this invention is directed to methods for treating or preventing IBD using amide compounds. This invention is also directed to pharmaceutical

BACKGROUND OF THE INVENTION The present invention is directed to methods of treating vascular inflammatory pathologies such as atheroslcerosis and stroke. In particular, the invention is directed to the use of certain compounds having potent anti-inflammatory and anti-oxidant activity. Free radical

BACKGROUND OF THE INVENTION A. Field of the Invention The present invention relates to novel hindered amides and more particularly relates to multicycloalkyl and azamulticycloalkyl amides which are 5-lipoxygenase inhibitors and are useful as anti-inflammatory and anti-allergy agents. It is well

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel hindered amides and more particularly relates to multicycloalkyl and azamulticycloalkyl amides which are 5-lipoxygenase inhibitors and are useful as anti-inflammatory and anti-allergy agents. It is well

BACKGROUND OF THE INVENTION A. Field of the Invention The present invention relates to novel heterocyclic amides and more particularly relates to heterocyclic amides which are 5-lipoxygenase inhibitors and are useful as anti-inflammatory and anti-allergy agents. It is well recognized that

BACKGROUND OF THE INVENTION The present invention is directed to the provision of compounds having potent anti-inflammatory and anti-oxidant activity. The invention is further directed to compositions containing the compounds of the present invention for use in pharmaceutical applications. The

BACKGROUND OF THE PRESENT INVENTION The present invention is novel compounds, which are derivatives of hydroxybenzylamine and as such are related to capsaicin. The present compounds have antiinflammatory activity for the treatment of arthritis, asthma, Raynaud's disease, inflammatory bowel

STATE OF THE ART U.S. Pat. No. 4,486,438 describes racemic 4-hydroxy-2-(1-hydroxypropyl)-N-(2-thiazolyl)-8-trifluoromethyl-3-quinolin e-carboxamide as having analgesic activity. OBJECTS OF THE INVENTION It is an object of the invention to provide the novel compounds of formula I and their salts with

BACKGROUND OF THE INVENTION The present invention is directed to the provision of compounds having potent anti-inflammatory and anti-oxidant activity. The invention is further directed to compositions containing the compounds of the present invention for use in pharmaceutical applications. The

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to novel substituted di-[5-hydroxy-2(5H)-4-furanonyl]alkylmethyl- alkane-dioates and N,N-bis-[5-hydroxy-2(5H)-4-furanonyl]alkylmethyl- dialkanoic acid amides which are active as anti-inflammatory agents. The

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention is directed to novel substituted di-[5-hydroxy-2(5H)-4-furanonyl]methyl- alkane-dioates and N,N-bis-[5-hydroxy-2(5H)-4-furanonyl]methyl- dialkanoic acid amides which are active as anti-inflammatory agents. The present

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to the treatment of indolent dermal irritations. More specifically, it concerns treatment of persistent inflammations such as chemical ulcers, herpes ulcers, radiation burns, psoriasis and sunburn. 2. General Background of

The present invention relates to aerosol compositions containing a carrier agent capable agent capable of recognizing and binding to inflammatory and tumor foci mobilizing macrophages in their immediate environment, and an aerosol substrate. More especially, the present invention relates to aerosol